Food and Drug Law Institute Announces Writing Award Winners

WASHINGTON, Jan. 16 /PRNewswire-USNewswire/ — The Food and Drug Law Institute has announced the winners of the 2007-2008 H. Thomas Austern Memorial Writing Competition.

In the Short Paper Competition, Michael Kolber, a Harvard Law School Student, took first place for his article, Direct Final Rulemaking in the FDA: Lessons from the First Decade. Shengfeng Chen, a law student at the University of California, Hastings College of the Law, took second place for an article entitled Pathways to Patents: Applying the Written Description Requirement Doctrine To Patents On Biological Pathways.

In the Long Paper Competition, Benjamin R. Rossen, Harvard Law School, captured first place for his article, FDA’s Proposed Regulations to Expand Access to Investigational Drugs for Treatment Use: The Status Quo in the Guise of Reform while Matthew Gordon, also at Harvard Law School, took second place for his article, Why Researchers Might Have a Legal Duty to Disclose Individual Research Findings to Research Subjects.

Several of these articles have been published in FDLI’s Food and Drug Law Journal, the premier law journal for food and drug attorneys.

FDLI sponsors the Austern Writing Competition to encourage law students interested in the areas of law that affect food, drugs, medical devices, cosmetics and biologics. Entrants must be currently enrolled in a J.D. program at any of the nation’s accredited law schools.

The deadline for 2008-2009 entries is June 15, 2009. For details, visit FDLI’s website at www.fdli.org or contact Writing Award Competition, FDLI, 1155 15th St. NW, Suite 800, Washington, DC 20005. Tel. 202-222-0899, email: publications@fdli.org

Founded in 1949, FDLI publishes the award-winning, peer-reviewed Food and Drug Law Journal; the bimonthly magazine Update; FDA Directory; and dozens of books and publications for attorneys, regulatory affairs practitioners, scientists, health care professionals, government employees and marketers in the food and drug field. For more information, visit www.fdli.org

SOURCE Food and Drug Law Institute